Placental-derived stem cells: Culture, differentiation and challenges

Area of Science:

• Regenerative Medicine
• Cell Biology
• Biotechnology

Background:

• Stem cell therapy shows potential for treating diverse diseases.
• Placenta-derived stem cells (p-SCs) possess unique characteristics, bridging embryonic and mesenchymal stem cells.
• Ethical considerations are minimized as p-SCs are derived from medical waste.

Purpose of the Study:

• To review the biological properties, culture methods, and therapeutic potential of p-SCs.
• To explore the immunophenotype, isolation, and culture principles of p-SCs.
• To highlight preclinical applications and challenges in p-SC-based therapies.

Main Methods:

• Review of existing literature on p-SC biology and applications.
• Analysis of immunophenotype characterization, including surface marker expression.
• Examination of isolation and culture techniques (e.g., mechanical/enzymatic digestion, culture media).

Main Results:

• p-SCs exhibit properties of both embryonic and mesenchymal stem cells, including non-carcinogenicity and differentiation potential across germ layers.
• Preclinical studies demonstrate p-SC utility in neurological, hepatic, pancreatic, cardiac, muscular, pulmonary, and bone diseases.
• p-SCs are also explored for applications in tissue engineering.

Conclusions:

• Understanding p-SC differentiation mechanisms and achieving pure differentiated cell populations are crucial for clinical translation.
• Further research is needed to bridge the gap between preclinical findings and medical practice.
• p-SCs represent a viable and ethically sound option for future cell-based therapies.